Aneuploidy is observed in as much as 41% of non-dysplastic lesions of patients from IBD and continues to accrue until it becomes a virtually obligatory finding in CAC that is frequently associated with p53 loss (Fig. 2) [13, 36]. This evidence concerns the gene TP53 and inflammatory bowel disease.